This study examines the joint effect on cognition of selective serotonin re-uptake inhibitors (SSRIs) and cholinesterase inhibitors (AChEIs) in depressed patients affected by Alzheimer's disease (AD) living at home.

Rozzini, L., Chilovi, B., Conti, M., Bertoletti, E., Zanetti, M., Trabucchi, M.m., et al. (2010). Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors, 22(1), 114-119 [10.1017/S1041610209990184].

Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors

TRABUCCHI, MARCO MARIO;
2010-02-01

Abstract

This study examines the joint effect on cognition of selective serotonin re-uptake inhibitors (SSRIs) and cholinesterase inhibitors (AChEIs) in depressed patients affected by Alzheimer's disease (AD) living at home.
feb-2010
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore BIO/14 - FARMACOLOGIA
English
Con Impact Factor ISI
Fluoxetine; Male; Serotonin Uptake Inhibitors; Cognition Disorders; Citalopram; Female; Movement Disorders; Humans; Cholinesterase Inhibitors; Paroxetine; Aged; Neuropsychological Tests; Alzheimer Disease; Depressive Disorder, Major; Severity of Illness Index; Cognition
Rozzini, L., Chilovi, B., Conti, M., Bertoletti, E., Zanetti, M., Trabucchi, M.m., et al. (2010). Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors, 22(1), 114-119 [10.1017/S1041610209990184].
Rozzini, L; Chilovi, B; Conti, M; Bertoletti, E; Zanetti, M; Trabucchi, Mm; Padovani, A
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/14659
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 44
social impact